Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature

被引:13
作者
De Luca, Pietro [1 ]
Scarpa, Alfonso [1 ]
De Bonis, Egidio [1 ]
Cavaliere, Matteo [2 ]
Viola, Pasquale [3 ]
Gioacchini, Federico Maria [4 ]
Ralli, Massimo [5 ]
Ettore, Cassandro [1 ]
Claudia, Cassandro [6 ]
机构
[1] Univ Salerno, Dept Med Surg & Dent, Salerno, Italy
[2] Univ Hosp San Giovanni Dio & Ruggi DAragona, Otolaryngol Dept, Salerno, Italy
[3] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Unit Audiol, Reg Ctr Cochlear Implants & ENT Dis, Catanzaro, Italy
[4] Polytech Univ Marche, Dept Clin & Mol Sci, ENT Unit, Ancona, Italy
[5] Univ Sapienza, Dept Sense Organs, Rome, Italy
[6] Univ Turin, Dept Surg Sci, Turin, Italy
关键词
COVID-19; Ototoxicity; Chloroquine; Hydroxychloroquine; Hearing loss; Tinnitus; CHILD; PHOSPHATE;
D O I
10.1016/j.amjoto.2020.102640
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: Current clinical evidences do not support any specific treatment against SARS-CoV-2. Chloroquine (CQ) and hydroxychloroquine (HCQ) are typically used in the treatment of rheumatoid arthritis, systemic lupus erythematosus and malaria; they have been considered for off-label and compassionate use in several countries against moderate to severe cases of COVID-19 and there's actually a massive demand of these two drugs. The aim of this paper is to briefly review the published literature, summarizing evidences about audiological implications after CQ and HCQ treatment. Methods: We conducted a review of the literature on Medline and Pubmed platforms from 27th May 2020 to 30 May 2020. We combined MeSH terms of "chloroquine", "hydroxychloroquine", "ototoxicity", "hearing loss", "tinnitus", "deafness" and "hearing". Publications with relevant data were included. Selected data (authors, country and year; sample size; study design; audiological side effects) were extracted and summarized in a table. Results: Of 45 initial studies, 14 met inclusion criteria. The authors found xix cases of HCQ ototoxicity; Tinnitus was reported in 2 cases, and it was found to be reversible or irreversible. Sensorineural hearing loss after HCQ use was reported in 7 patients; it was found to be irreversible or partially reversible after discontinuation of HCQ in 6 cases. Eight papers reporting CQ ototoxicity were; tinnitus was not reported by any authors. Sensorineural hearing loss after taking CQ was reported in 6 patients; it was found to be irreversible after discontinuation of CQ in 5 patients. One patient showed abnormal gait after a single intramuscular injection of CQ. Thirteen patients' Auditory Brainstem Response (ABR) were found to be abnormal, but they resolved after CQ discontinuation. Conclusions: CQ and HCQ related ototoxicity is widely reported in the literature although the pathophysiological mechanism is not well known. Current data are not sufficient enough to support the use of CQ and HCQ as therapy for COVID-19, but considering the growing demand for these two drugs and the number of people around the world who have taken and will take CQ and HCQ, it must necessarily consider the clinical and social impact of long term audiological side effects.
引用
收藏
页数:4
相关论文
共 29 条
[1]   ALTERATIONS OF AUDITORY EVOKED-POTENTIALS DURING THE COURSE OF CHLOROQUINE TREATMENT [J].
BERNARD, P .
ACTA OTO-LARYNGOLOGICA, 1985, 99 (3-4) :387-392
[2]   Chloroquine gestational use in systemic lupus erythematosus:: assessing the risk of child ototoxicity by pure tone audiometry [J].
Borba, EF ;
Turrini, JR ;
Kuruma, K ;
Bertola, C ;
Pedalini, MEB ;
Lorenzi, MC ;
Bonfá, E .
LUPUS, 2004, 13 (04) :223-227
[3]   Chloroquine ototoxicity [J].
Bortoli, Rodrigo ;
Santiago, Mittermayer .
CLINICAL RHEUMATOLOGY, 2007, 26 (11) :1809-1810
[4]  
Cianfrone G, 2011, EUR REV MED PHARMACO, V15, P601
[5]   Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature [J].
Costedoat-Chalumeau, N ;
Amoura, Z ;
Huong, DLT ;
Lechat, P ;
Piette, JC .
AUTOIMMUNITY REVIEWS, 2005, 4 (02) :111-115
[6]   Hydroxychloroquine ototoxicity in a child with idiopathic pulmonary haemosiderosis [J].
Coutinho, MB ;
Duarte, I .
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2002, 62 (01) :53-57
[7]   Impact of the COVID-19 Pandemic on Otolaryngology Residency: A Real-Life Experience [J].
De Luca, Pietro ;
Colacurcio, Vito ;
De Bonis, Egidio ;
Petrosino, Michele ;
Bisogno, Antonella ;
Troisi, Donato ;
Calvanese, Matteo ;
Marra, Pasquale .
ENT-EAR NOSE & THROAT JOURNAL, 2020, 99 (09) :563-564
[8]   Nasal, pharyngeal and laryngeal endoscopy procedures during COVID-19 pandemic: available recommendations from national and international societies [J].
De Luca, Pietro ;
Scarpa, Alfonso ;
Ralli, Massimo ;
De Vincentiis, Marco ;
Cassandro, Ettore ;
Chiarella, Giuseppe ;
Cassandro, Claudia .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (07) :2151-2153
[9]   Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus [J].
de Novaes Fernandes, Mariana Rita ;
Rosa Soares, Debora Bergami ;
Thien, Chan I. ;
Carneiro, Sueli .
ANAIS BRASILEIROS DE DERMATOLOGIA, 2018, 93 (03) :469-470
[10]   OTOTOXICITY OF CHLOROQINE PHOSPHATE - CASE-REPORT [J].
DWIVEDI, GS ;
MEHRA, YN .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1978, 92 (08) :701-703